<DOC>
	<DOCNO>NCT01042678</DOCNO>
	<brief_summary>The purpose study assess safety tolerability MP0112 ( novel , potentially long act VEGF inhibitor ) patient diabetic retinal edema .</brief_summary>
	<brief_title>Study MP0112 Intravitreal Injection Patients With Diabetic Macular Edema</brief_title>
	<detailed_description />
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<criteria>Male female age 18 year old Macular edema due diabetic retinopathy Bestcorrected visual acuity study eye 20/40 20/400 Central subfield thickness ≥ 250 micron OCT Females childbearing potential must negative serum pregnancy test Screening Male subject must : 1 ) surgically sterilize least 6 month , 2 ) use appropriate method barrier contraception ( e.g. , condom spermicide ) advise sexual partner childbearing potential must also use reliable method contraception ( e.g. , hormonal contraceptive , intrauterine device , diaphragm spermicide ) study 30 day study drug administration . Ability understand nature study give write informed consent Willing , commit , able return ALL clinic visit complete studyrelated procedure Any indication irreversible vision loss significant atrophy , scar , fibrosis , hyperpigmentation fovea Presence significant ocular abnormality study eye prevent retinal assessment , include medium opacity , cataract , inadequate papillary dilation Presence vision loss another ocular disease DME History intraocular surgery within 3 month Baseline History intraocular injection antiVEGF agent steroid within 3 month Baseline History laser photocoagulation macular edema within 4 month prior Baseline Uncontrolled hypertension &gt; 140 systolic &gt; 95 diastolic HbA1C ≥ 12 % Creatinine : &gt; 1.5 x upper limit normal ( ULN ) Alanine transaminase ( ALT ) , aspartate transaminase ( AST ) , gammaglutamyl transferase ( GGT ) : &gt; ULN White blood cell ( WBC ) , hematocrit , platelet : &lt; low limit normal ( LLN ) Heart rate &lt; 60 beat per minute ( bpm ) history clinically significant bradycardia History human immunodeficiency virus ( HIV ) , chronic hepatitis B , chronic hepatitis C infection Subjects infection require hospitalization and/or antibiotic treatment 14 day prior Baseline Subjects medical condition judgment investigator could poise unacceptable risk subject compromise interpretation data collect</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
</DOC>